[
Adifbair, A., Saleem, M., Lanctôt, K., Herrmann, N. (2016). Potential biomarkers for depression associated with coronary artery disease: A critical review. Curr. Mol. Med., 16, 137–164.10.2174/1566524016666160126144143
]Search in Google Scholar
[
Antoniades, C., Antonopoulos, A. S., Bendall, J. K., Channon, K. M. (2009). Targeting redox signaling in the vascular wall: from basic science to clinical practice. Curr. Pharm. Des., 15 (3), 329–342.10.2174/138161209787354230
]Search in Google Scholar
[
Bal, N., Acar, S. T., Yazıcı, A., Yazıcı, K., Tamer, L. (2012). Altered levels of malondialdehyde and vitamin E in major depressive disorder and generalized anxiety disorder. J. Psychiatry Neurol. Sci., 25 (3), 206–211.
]Search in Google Scholar
[
Barth, J., Schumacher, M., Herrmann-Lingen, C. (2004). Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom. Med., 66 (6), 802–813.10.1097/01.psy.0000146332.53619.b2
]Search in Google Scholar
[
Bauer, L. K., Caro, M. A., Beach, S. R., Mastromauro, C. A., Lenihan, E., Januzzi, J. L., Huffman, J. C. (2012). Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Amer. J. Cardiol., 109 (9), 1266–1271.10.1016/j.amjcard.2011.12.017
]Search in Google Scholar
[
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., Penninx, B. W. (2015). Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology, 51, 164–175.10.1016/j.psyneuen.2014.09.025
]Search in Google Scholar
[
Brouns, R., Verkerk, R., Aerts, T., Surgeloose D., Wauters, A., Scharpé, S., De Deyn, P. P. (2010). The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke. Neurochem. Res., 35 (9), 1315–1322.10.1007/s11064-010-0187-2
]Search in Google Scholar
[
Brown, A. D., Barton, D. A., Lambert, G. W. (2009). Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs, 23 (7), 583–602.10.2165/00023210-200923070-00004
]Search in Google Scholar
[
Huffman, J. C., Mastromauro, C. A., Sowden, G. L., Wittmann, C., Rodman, R., Januzzi, J. L. (2011). A collaborative care depression management program for cardiac inpatients: Depression characteristics and in-hospital outcomes. Psychosomatics, 52 (1), 26–33.10.1016/j.psym.2010.11.021
]Search in Google Scholar
[
Carney, R. M., Freedland, K. E. (2008). Depression in patients with coronary heart disease. Amer. J. Med., 121 (11, Suppl 2), S20–S27.10.1016/j.amjmed.2008.09.010
]Search in Google Scholar
[
Cassano, P., Fava, M. (2002). Depression and public health: An overview. J. Psychosom. Res., 53 (4), 849–857.10.1016/S0022-3999(02)00304-5
]Search in Google Scholar
[
Celano, C. M., Huffman, J. C. (2011). Depression and cardiac disease: A review. Cardiol. Rev., 19 (3), 130–142.10.1097/CRD.0b013e31820e810621464641
]Search in Google Scholar
[
Chauvet-Géliniera, J. C., Trojak B., Vergès-Patois B., Cottin Y., Bonin B. (2013). Review on depression and coronary heart disease. Arch. Cardiovasc. Dis., 106 (2), 103–110.10.1016/j.acvd.2012.12.00423527914
]Search in Google Scholar
[
Cheraghi, M., Ahmadvand, H., Maleki, A., Babaeenezhad, E., Shakiba, S., Hassanzadeh, F., (2019). Oxidative stress status and liver markers in coronary heart disease. Rep. Biochem. Mol. Biol., 8 (1), 49–55.
]Search in Google Scholar
[
Cumurcu, B. E., Ozyurt, H., Etikan I., Demir S., Karlidag R. (2009). Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment. Psychiatry Clin. Neurosci., 63 (5), 639–645.10.1111/j.1440-1819.2009.02004.x19674383
]Search in Google Scholar
[
De Hert, M., Detraux, J., Vancampfort, D. (2018). The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin. Neurosci., 20 (1), 31–40.10.31887/DCNS.2018.20.1/mdehert
]Search in Google Scholar
[
Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A., Khandia, R., Karthik, K., Tiwari, R., Yatoo, M. I., Bhatt, P., Chakraborty, S., Singh, K. P., Iqbal, H., Chaicumpa, W., Joshi, S. K. (2019). Biomarkers in stress related diseases/disorders: Diagnostic, prognostic, and therapeutic values. Front Mol. Biosci., 6,p.91.10.3389/fmolb.2019.00091684307431750312
]Search in Google Scholar
[
Dhar, A. K., Barton, D. A. (2016). Depression and the link with cardiovascular disease. Front Psychiatry, 7, 33.10.3389/fpsyt.2016.00033480017227047396
]Search in Google Scholar
[
Ērglis, A., Dzērve-Tāluts, V., Bajāre, I. (2020). Latvijas iedzīvotāju kardiovaskulāro un citu neinfekcijas slimību riska faktoru šķērsgriezuma pētījums [Cross-sectional study of cardiovascular and noninfectious diseases risk factors among Latvia’s inhabitants]. Latvijas Universitātes Kardioloģijas un reģeneratīvās medicīnas zinātniskais institūts, Rīga. 13 pp. (in Latvian). https://esparveselibu.lv/sites/default/files/2020-10/LATVIJAS%20IEDZĪVOTĀJU%20KARDIOVASKULĀRO%20%20UN%20CITU%20NEINFEKCIJAS%20SLIMĪBU%20RISKA%20FAKTORU%20ŠĶĒRSGRIEZUMA%20PĒTĪJUMS%20.pdf (accessed 12.03.2022).
]Search in Google Scholar
[
Feng, Z., Hu, W., Marnett, L. J., Tang, M. S. (2006). Malondialdehyde, a major endogenous lipid peroxidation product, sensitizes human cells to UV and BPDE-induced killing and mutagenesis through inhibition of nucleotide excision repair. Mutat. Res., 601 (1–2), 125–136.10.1016/j.mrfmmm.2006.06.00316872641
]Search in Google Scholar
[
Frasure-Smith, N., Lespérance, F. (2010). Depression and cardiac risk: Present status and future directions. Heart, 96 (3), 173–176.10.1136/hrt.2009.18695719861300
]Search in Google Scholar
[
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392 (10159), 1789–1858.
]Search in Google Scholar
[
Glassman, A. H., Bigger, J. T., Gaffney, M., Shapiro, A. P., Swenson, J. R. (2006). Onset of major depression associated with acute coronary syndromes: Relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch. Gen. Psychiatry, 63 (3), 283–288.10.1001/archpsyc.63.3.28316520433
]Search in Google Scholar
[
Goodman, J., Shimbo D., Haas, D. C., Davidson, K. W., Rieckmann, N. (2008). Incident and recurrent major depressive disorder and coronary artery disease severity in acute coronary syndrome patients. J. Psychiatr. Res., 42 (8), 670–675.10.1016/j.jpsychires.2007.07.004239872017709116
]Search in Google Scholar
[
Guck, T. P., Kavan, M. G., Elsasser, G. N., Barone, E. J. (2011). Assessment and treatment of depression following myocardial infarction. Amer. Fam. Physician, 64 (4), 641–648.
]Search in Google Scholar
[
Halaris, A. (2017). Inflammation-associated co-morbidity between depression and cardiovascular disease. Curr. Top Behav. Neurosci., 31, 45–70.10.1007/7854_2016_2827830572
]Search in Google Scholar
[
Hasnain, M., Vieweg, W. V., Lesnefsky, E. J., Pandurangi, A. K. (2011). Depression screening in patients with coronary heart disease: A critical evaluation of the AHA guidelines. J. Psychosom. Res., 71 (1), 6–12.10.1016/j.jpsychores.2010.10.00921665006
]Search in Google Scholar
[
Huffman, J. C., Celano, C. M., Beach, S. R., Motiwala, S. R., Januzzi, J. L. (2013). Depression and cardiac disease: Epidemiology, mechanisms, and diagnosis. Cardiovasc. Psychiatry Neurol., 2013, 695925.10.1155/2013/695925
]Search in Google Scholar
[
Januzzi, J. L., Jr, Stern, T. A., Pasternak, R. C., DeSanctis, R. W. (2000). The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch. Intern. Med., 160 (13), 1913–1921.10.1001/archinte.160.13.191310888966
]Search in Google Scholar
[
Jeon, S. W., Kim, Y. K. (2017). Inflammation-induced depression: Its patho-physiology and therapeutic implications. J. Neuroimmunol., 313, 92–98.10.1016/j.jneuroim.2017.10.01629153615
]Search in Google Scholar
[
Jiang, W., Krishnan, R., Kuchibhatla, M., Cuffe, M. S., Martsberger, C., Arias, R. M., O’Connor, C. M., SADHART-CHF Investigators (2011). Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). Amer. J. Cardiol., 107 (4), 545–551.10.1016/j.amjcard.2010.10.013307363021295172
]Search in Google Scholar
[
Kander, M. C., Cui, Y., Liu, Z. (2017). Gender difference in oxidative stress: A new look at the mechanisms for cardiovascular diseases. J. Cell Mol. Med., 21 (5), 1024–1032.10.1111/jcmm.13038538716927957792
]Search in Google Scholar
[
Kaya, Y., Çebı, A., Söylemez, N., Demır, H., Alp, H. H., Bakan, E. (2012). Correlations between oxidative DNA damage, oxidative stress and coen-zyme Q10 in patients with coronary artery disease. Int. J. Med. Sci., 9 (8), 621–626.10.7150/ijms.4768346584523055813
]Search in Google Scholar
[
Khandaker, G. M., Zuber, V., Rees, J., Carvalho, L., Mason, A. M., Foley, C. N., Gkatzionis, A., Jones, P. B., Burgess, S. (2020). Shared mechanisms between coronary heart disease and depression: Findings from a large UK general population-based cohort. Mol. Psychiatry, 25 (7), 1477–1486.10.1038/s41380-019-0395-3730300930886334
]Search in Google Scholar
[
Khawaja, I. S., Westermeyer, J. J.., Gajwani, P., Feinstein, R. E. (2009). Depression and coronary artery disease: The association, mechanisms, and therapeutic implications. Psychiatry (Edgmont), 6 (1), 38–51.
]Search in Google Scholar
[
Kuller, L. H., Arnold, A. M., Psaty, B. M., Robbins, J. A., O’Leary, D. H., Tracy, R. P., Burke, G. L., Manolio, T. A., Chaves, P. H. M. (2006). 10-year follow-up of subclinical cardiovascular disease and risk of coronary heart disease in the Cardiovascular Health Study. Arch. Intern. Med., 166 (1), 71–78.10.1001/archinte.166.1.7116401813
]Search in Google Scholar
[
Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M. A., van Zyl, L. T., Baker, B., Swenson, J. R., Ghatavi, K., Abramson, B. L., Dorian, P., Guertin, M. C., CREATE Investigators (2007). Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (CREATE) trial. JAMA, 297 (4), 367–379.10.1001/jama.297.4.36717244833
]Search in Google Scholar
[
Lin, D., Wang, L., Yan, S., Zhang, Q., Zhang, J. H., Shao, A. (2019). The role of oxidative stress in common risk factors and mechanisms of cardiocerebrovascular ischemia and depression. Oxid. Med. Cell Longev., 2019, 2491927.10.1155/2019/2491927
]Search in Google Scholar
[
Liu, T., Zhong S., Liao, X., Chen J., He, T., Lai, S., Jia Y. (2015). A meta-analysis of oxidative stress markers in depression. PLoS One, 10 (10), e0138904.10.1145/2818302
]Search in Google Scholar
[
Maes, M., Galecki, P., Chang, Y. S., Berk, M. (2011). A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry, 35 (3), 676–692.10.1016/j.pnpbp.2010.05.00420471444
]Search in Google Scholar
[
Matthews, K. A., Schott, L. L., Bromberger, J. T., Cyranowski, J. M., Everson-Rose, S. A., Sowers, M. (2010). Are there bidirectional associations between depressive symptoms and C-reactive protein in mid-life women? Brain Behav. Immun., 24 (1), 96–101.10.1016/j.bbi.2009.08.005
]Search in Google Scholar
[
Mattina, G. F., Van Lieshout, R. J., Steiner, M. (2019). Inflammation, depression and cardiovascular disease in women: The role of the immune system across critical reproductive events. Ther. Adv. Cardiovasc. Dis., 13, doi: 10.1177/1753944719851950.10.1177/1753944719851950654565131144599
]Search in Google Scholar
[
Mazereeuw, G., Herrmann, N., Andreazza, A. C., Scola, G., Ma, D., Oh, P. I., Lanctōt, K. L. (2017). Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients. Brain Behav. Immun., 60, 136–141.10.1016/j.bbi.2016.10.00527742581
]Search in Google Scholar
[
Mazza, M., Lotrionte, M., Biondi-Zoccai, G., Abbate, A., Sheiban, I., Romagnoli, E. (2010). Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: Evidence from a meta-analysis. J. Psycho-pharmacol., 24 (12), 1785–1792.10.1177/026988110934817619965939
]Search in Google Scholar
[
Moryś, J. M., Bellwon, J., Adamczyk, K., Gruchała, M. (2016). Depression and anxiety in patients with coronary artery disease, measured by means of self-report measures and clinician-rated instrument. Kardiol. Pol., 74 (1), 53–60.10.5603/KP.a2015.011626101024
]Search in Google Scholar
[
Moylan, S., Berk, M., Dean O. M., Samuni Y., Williams, L. J., O’Neil, A., Hayley, A. C., Pasco, J. A., Anderson, G., Jacka, F. N., Maes, M. (2014). Oxidative & nitrosative stress in depression: why so much stress? Neurosci. Biobehav. Rev., 45, 46–62.10.1016/j.neubiorev.2014.05.00724858007
]Search in Google Scholar
[
Murray, C. J., Lopez, A. D. (2013). Measuring the global burden of disease. New Engl. J. Med., 369 (5), 448–57.10.1056/NEJMra120153423902484
]Search in Google Scholar
[
Myers, V., Gerber, Y., Benyamini, Y., Goldbourt, U., Drory, Y. (2012). Post-myocardial infarction depression: Increased hospital admissions and reduced adoption of secondary prevention measures — a longitudinal study. J. Psychosom. Res., 72 (1), 5–10.10.1016/j.jpsychores.2011.09.00922200515
]Search in Google Scholar
[
Nemeroff, C. B., Goldschmidt-Clermont, P. J. (2012). Heartache and heartbreak — the link between depression and cardiovascular disease. Nat. Rev. Cardiol., 9 (9), 526–539.10.1038/nrcardio.2012.9122733213
]Search in Google Scholar
[
Nezafati, M. H, Vojdanparast, M., Nezafati, P. (2015). Antidepressants and cardiovascular adverse events: A narrative review. ARYA Atheroscl, 11 (5), 295–304.
]Search in Google Scholar
[
Nikkheslat, N., Zunszain, P. A, Horowitz, M. A, Barbosa, I. G., Parker, J. A., Myint, A. M., Schwarz, M. J., Tylee, A. T., Carvalho, L. A., Pariante, C. M. (2015). Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression. Brain Behav. Immun., 48, 8–18.10.1016/j.bbi.2015.02.00225683698
]Search in Google Scholar
[
GBD 2016 Causes of Death Collaborators (2017). Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390 (10100), 1151–1210.
]Search in Google Scholar
[
Pezeshkian, M., Nouri, M., Zahraei, M., Afrasiabi, A., Abadi, N. A. (2001). Study of MDA, antioxidant vitamins, lipoproteins serum levels and anthropometry parameters in coronary artery disease patients. Med. J. Islam. Acad. Sci., 14, 5–8.
]Search in Google Scholar
[
Pizzi, C., Mancini, S., Angeloni, L., Fontana, F., Manzoli, L., Costa, G. M. (2009). Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin. Pharmacol. Ther., 86 (5), 527–532.10.1038/clpt.2009.12119641491
]Search in Google Scholar
[
Puppel, K., Kapusta, A., Kuczyñska, B. (2015). The etiology of oxidative stress in the various species of animals, a review. J. Sci. Food Agric., 95 (11), 2179–2184.10.1002/jsfa.701525418967
]Search in Google Scholar
[
Rees, J. N., Florang, V. R., Anderson, D. G., Doorn, J. A. (2007). Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate. Chem. Res. Toxicol., 20 (10), 1536–1542.10.1021/tx700248y17887726
]Search in Google Scholar
[
Del Rio, D., Stewart, A. J., Pellegrini, N. (2005). A review of recent studies on malonaldehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis., 15 (4), 316–328.10.1016/j.numecd.2005.05.003
]Search in Google Scholar
[
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020). Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J. Amer. Coll. Cardiol., 76 (25), 2982–3021.10.1016/j.jacc.2020.11.010775503833309175
]Search in Google Scholar
[
Sanchis-Gomar, F., Perez-Quilis, C., Leischik, R., Lucia, A. (2016). Epidemiology of coronary heart disease and acute coronary syndrome. Ann. Transl. Med., 4 (13), 256.10.21037/atm.2016.06.33495872327500157
]Search in Google Scholar
[
Sarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., Kirli, S. (2007). Major depressive disorder is accompanied with oxidative stress: Short-term antidepressant treatment does not alter oxidative antioxidative systems. Hum. Psychopharmacol., 22 (2), 67–73.10.1002/hup.82917299810
]Search in Google Scholar
[
Swardfager, W., Herrmann, N., Marzolini, S., Saleem, M., Farber, S. B., Kiss, A., Oh, P. I., Lanctôt, K. L. (2011). Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease. J. Clin. Psychiatry, 72 (9), 1181–1188.10.4088/JCP.09m05810blu21208573
]Search in Google Scholar
[
Trebatická, J., Dukát, A., Ďuračková, Z., Muchová, J. (2017). Cardiovascular diseases, depression disorders and potential effects of Omega-3 fatty acids. Physiol. Res., 66 (3), 363–382.10.33549/physiolres.93343028248536
]Search in Google Scholar
[
Van der Kooy, K., van Hout, H., Marwijk, H., Marten, H., Stehouwer, C., Beekman, A. (2007). Depression and the risk for cardiovascular diseases: Systematic review and meta analysis. Int. J. Geriatr. Psychiatry, 22 (7), 613–626.10.1002/gps.172317236251
]Search in Google Scholar
[
van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G., Ormel, J., van Veldhuisen, D. J., van den Brink, R. H., van den Berg, M. P. (2004). Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosom. Med., 66 (6), 814–822.10.1097/01.psy.0000146294.82810.9c15564344
]Search in Google Scholar
[
Vaváková, M., Ďuračková, Z., Trebatická, J. (2015). Markers of oxidative stress and neuroprogression in depression disorder. Oxid. Med. Cell. Longev., 2015, 898393.10.1155/2015/898393445328026078821
]Search in Google Scholar
[
Vichova, T., Motovska, Z. (2013). Oxidative stress: Predictive marker for coronary artery disease. Exp. Clin. Cardiol., 18 (2), e88–e91.
]Search in Google Scholar
[
Voicehovskis, V. V., Margolina, J., Voicehovska, J. G, Miksons, A. (2013). Validation of the Latvian version of the Geriatric depression scale (GDS). Psychother. Psychosom., 82 (S1), 122–123.
]Search in Google Scholar
[
Wang, Q., Liu, D., Song, P., Zou, M. H. (2015). Tryptophan- kynurenine pathway is dysregulated in inflammation, and immune activation. Front Biosci. (Landmark Ed), 20, 1116–1143.10.2741/4363491117725961549
]Search in Google Scholar
[
Whooley, M. A., Wong, J. M. (2013). Depression and cardiovascular disorders. Annu. Rev. Clin. Psychol., 9, 327–354.10.1146/annurev-clinpsy-050212-18552623537487
]Search in Google Scholar
[
Wirleitner, B., Rudzite, V., Neurauter, G., Murr, C., Kalnins, U., Erglis, A., Trusinskis, K., Fuchs, D. (2003). Immune activation and degradation of tryptophan in coronary heart disease. Eur. J. Clin. Invest., 33 (7), 550–554.10.1046/j.1365-2362.2003.01186.x12814390
]Search in Google Scholar
[
World Health Organization, Mendis, S., Puska, P., Norrving, B. (eds.) (2011). Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization. 155 pp.
]Search in Google Scholar
[
Yekehtaz, H., Farokhnia, M., Akhondzadeh, S. (2013). Cardiovascular considerations in antidepressant therapy: An evidence-based review. J. Tehran Heart Cent., 8 (4), 169–176.
]Search in Google Scholar
[
Zuo, H., Ueland, P. M., Ulvik, A., Eussen, S. J., Vollset, S. E., Nygård, O., Midttun, Ø., Theofylaktopoulou, D., Meyer, K., Tell, G. S. (2016). Plasma biomarkers of inflammation, the kynurenine pathway, and risks of all-cause, cancer, and cardiovascular disease mortality. Amer. J. Epidemiol., 183 (4), 249–258.10.1093/aje/kwv242475328326823439
]Search in Google Scholar
